Number of shares and voting rights as at 31/05/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st May.
Update on legal proceedings progress
During the hearing on May 9, 2019, the Commercial Court of Mont de Marsan examined three proposals for takeover of activity submitted by candidates.
Read the press release (in French)
Number of shares and voting rights as at 30/04/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th April.
Update on legal proceedings progress
According to the judgment of 25 January 2019 declaring the opening of the insolvency proceedings of Europlasma and the Group companies (see press release of 25/01/2019), the Commercial Court of Mont de Marsan set an observation period of 6 months to implement sustainable industrial projects and safeguard jobs.
Read the press release (in French)
Details concerning BSAR exercise
As part of the ongoing proceedings, Europlasma recalls that the share price as well as BSAR B and C of the Company have been suspended since 20 March 2019.
Read the press release (in French)
Number of shares and voting rights as at 31/03/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st March.
Europlasma shares trading is suspended pending a press release
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today at 9:00am (Paris time).
Read the press release (in French)
Number of shares and voting rights as at 28/02/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.
Termination of the liquidity contract
The company announces that the liquidity contract entrusted to Kepler Cheuvreux ended on 5 February 2019.